Cited by 84Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchAsthma and respiratory diseases

Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double‐blind placebo‐controlled clinical trial

Rondón, C., Campo, P., Salas, M., Aranda, A., Molina, A., González, M., Galindo, L., Mayorga, C. +2 more·2016·Allergy

Abstract

The effects of allergen immunotherapy ( AIT ) on local allergic rhinitis ( LAR ) are largely unknown. We conducted the first randomized, double‐blind, placebo‐controlled ( DBPC ), phase II trial of D. pteronyssinus ( DP ) subcutaneous AIT ( DP ‐ AIT ) on LAR (clinicaltrials.gov identifier: NCT 02123316). Thirty‐six LAR patients received Pangramin PLUS DP or placebo for 24 months. The primary endpoints were symptoms, medication scores, and medication‐free days. The secondary included skin test, serum specific IgE and IgG4, nasal allergen provocation test ( NAPT ), and adverse events. AIT ‐ DP produced significant improvements in both primary and secondary endpoints vs placebo. After 12 months of AIT ‐ DP , we detected a significant and marked increase in allergen tolerance with negative NAPT in 50% of patients, and significant increases of serum sIgG 4. Immunotherapy was well tolerated; no systemic reactions were reported. This study demonstrated that AIT ‐ DP is a safe and clinically effective treatment for LAR , confirming that LAR is a new indication for AIT.

Integrity signals

Registry

Crossref · 10.1111/all.12889

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Mite sublingual immunotherapy relieves nasal symptoms in patients with local allergic rhinitis.

    “A clinical trial with mite SLIT demonstrated relief of nasal symptoms in addition to a negative nasal provocation result in 50% of patients with local allergic rhinitis [177].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [177]

  • Mite sublingual immunotherapy results in a negative nasal provocation result in 50% of patients with local allergic rhinitis.

    “A clinical trial with mite SLIT demonstrated relief of nasal symptoms in addition to a negative nasal provocation result in 50% of patients with local allergic rhinitis [177].”

    From Position Paper on Nasal Obstruction: Evaluation and Treatment (2018) · cites this paper as [177]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rondón, C., Campo, P., Salas, M., Aranda, A., Molina, A., González, M., Galindo, L., Mayorga, C., Torres, M. J., & Blanca, M.
Affiliations
  • Hospital Regional Universitario de Málaga (ES)
  • Allergy Unit IBIMA‐Regional University Hospital of Málaga UMA Malaga Spain
Corresponding author
Rondón, C.
Venue
Allergy
Publisher
Wiley
Published
2016-04-13
Volume
71
Issue
7
Pages
1057-1061
ISSN
  • 0105-4538 (ISSN-L)
  • 1398-9995
OpenAlex
W2311528704
Cited by
84
References
5
Citations by year
2026: 4 · 2025: 4 · 2024: 8 · 2023: 6 · 2022: 11 · 2021: 10 · 2020: 13 · 2019: 8 · 2018: 10 · 2017: 8 · 2016: 2
FWCI
7.53
Type
journal article
Language
en
Open access
closed
Locations
  • Allergy (publishedVersion)
  • PubMed (publishedVersion)
Funders
Instituto de Salud Carlos III
Topics
  • Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
  • Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
  • Health Sciences › Medicine › Physiology › Asthma and respiratory diseases
Keywords
allergen immunotherapy, house dust mites, Dermatophagoides pteronyssinus, local allergic rhinitis, subcutaneous immunotherapy, allergen tolerance, serum IgG4, nasal allergen provocation test, treatment safety
MeSH terms
Allergens, Animals, Desensitization, Immunologic, Humans, Treatment Outcome, Antigens, Dermatophagoides, Dermatophagoides pteronyssinus, Rhinitis, Allergic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review